Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/126305
Title: | Specific Jak3 Downregulation in Lymphocytes Impairs γc Cytokine Signal Transduction and Alleviates Antigen-driven Inflammation In Vivo |
Author: | Gómez Valadés, Alicia G. Llamas, María Blanch, Sílvia Perales Losa, Carlos Román, Juan Gómez Casajús, Lluís Mascaró, Cristina |
Keywords: | Citoquines Immunoteràpia Cytokines Immunotheraphy |
Issue Date: | 1-Sep-2012 |
Publisher: | Cell Press |
Abstract: | Jak3, one of the four members comprising the Jak family of cytosolic tyrosine kinases, has emerged as a promising target for nontoxic immunotherapies. Although a number of Jak inhibitors has already demonstrated efficacy, they suffer from secondary effects apparently associated to their pan-Jak activity. However, whether selective Jak3 inhibition would afford therapeutic efficacy remains unclear. To address this question we have investigated the immunosuppressive potential of selective Jak3 intervention in lymphocytes using RNA interference (RNAi) technology in vitro and in vivo. Using synthetic small interference RNA (siRNA) sequences we achieved successful transfections into human and mouse primary T lymphocytes. We found that Jak3 knockdown was sufficient to impair not only interleukin-2 (IL-2) and T cell receptor (TCR)-mediated cell activation in vitro, but also antigen-triggereds welling, inflammatory cell infiltration, and proinflammatory cytokine raise in vivo. Furthermore, Jak1 (which mediates gamma c cytokine signaling in conjunction with Jak3) cosilencing did not provide higher potency to the aforementioned immunosuppressant effects. Our data provides direct evidences indicating that Jak3 protein plays an important role in gamma c cytokine and antigen-mediated T cell activation and modulates Th1-mediated inflammatory disorders, all in all highlighting its potential as a target in immunosuppressive therapies. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1038/mtna.2012.37 |
It is part of: | Molecular Therapy, 2012, vol. 4, num. 1, p. e42 |
URI: | http://hdl.handle.net/2445/126305 |
Related resource: | https://doi.org/10.1038/mtna.2012.37 |
ISSN: | 1525-0016 |
Appears in Collections: | Articles publicats en revistes (Ciències Fisiològiques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
632427.pdf | 1.79 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License